Skip to main content
Subscribe
  • Sign Up Free
  • Login
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Blogs
    • AI
    • Deals
    • Layoff Tracker
    • HIMSS 2023
  • Opinion
    • Breaking Bias
    • Commentaries
    • Letters
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top Innovators
    • Diversity in Healthcare
      • - Luminaries
      • - Top 25 Diversity Leaders
      • - Leaders to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Digital Health Transformation Summit
    • ESG: The Implementation Imperative Summit
    • Leadership Symposium
    • Social Determinants of Health Symposium
    • Women Leaders in Healthcare Conference
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Diversity Leaders Gala
    • Top 25 Women Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Hospital at Home
    • - Workplace of the Future
    • - AI and Digital Health
    • - Future of Staffing
    • - Hospital of the Future (Fall)
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Sponsored Video Series - One on One
    • Sponsored Video Series - Checking In with Dan Peres
  • Data & Insights
    • Data & Insights Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Providers
April 02, 2016 12:00 AM

Weaning pregnant women off opioids not harmful to fetus, study finds

Harris Meyer
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print
    “This is doable, but we have to set up behavioral programs because otherwise the relapse rate is too high,” said Dr. Craig Towers at High Risk Obstetrical Consultants in Knoxville, Tenn.

    Dr. Craig Towers' pregnant patients who were addicted to opioids frequently asked him whether he could help them get off drugs so their babies wouldn't suffer agonizing withdrawal symptoms after birth. Towers and his group, High Risk Obstetrical Consultants in Knoxville, Tenn., see 300 to 400 opiate-addicted pregnant women a year.

    Like most doctors across the country, Towers would tell them no, because detox would risk premature labor or even fetal death. Instead, he would recommend that they receive drug maintenance therapy with methodone or buprenorphine through their pregnancy.

    That's the long-standing opinion of the American College of Obstetricians and Gynecologists, even though it means newborns are likely to suffer neonatal abstinence syndrome, or NAS, and have to be hospitalized and slowly weaned off the opioid drug.

    But, challenged by his patients, Towers dug into the research literature and found studies suggesting that detoxification during pregnancy is not harmful. So he and his colleagues launched a five-year observational study of 301 opiate-addicted pregnant women who underwent four detox methods. The results were published recently in the American Journal of Obstetrics and Gynecology.

    They found no adverse fetal outcomes related to detoxification. In addition, among women who went through detox with accompanying intensive behavioral therapy, only about 17% of their newborns suffered NAS, primarily because the mother had relapsed.

    The findings may prompt more physicians to break with standard clinical practice and offer detox therapy during pregnancy, which could sharply reduce the number of babies with NAS.

    “I'm not saying, 'Change what you're doing and start detoxing everyone immediately,' ” said Towers, a professor of obstetrics and gynecology at the University of Tennessee Medical Center. “But for 40 years we've not been doing that because we thought it was harmful. We've now shown that's not true. This is doable, but we have to set up behavioral programs because otherwise the relapse rate is too high.”

    MH Takeaways

    Tennessee doctors are launching programs for addicted pregnant women that combine detox with behavioral therapy, breaking with standard practice to keep them on drug maintenance therapy.

    “I'm happy to see someone has had the courage to provide outcome data,” said Dr. Mark Hudak, a pediatrics professor at the University of Florida College of Medicine–Jacksonville, who co-authored a 2012 article in the journal Pediatrics on treating NAS babies. “This opens the door to further refinement to do this in a safe way to achieve the best results.”

    Hudak said doctors who wanted to try detox with pregnant women often were blocked by hospitals, fearful of the liability risk.

    The number of babies born with NAS in the U.S. grew five-fold between 2000 and 2012, with more than 21,000 infants suffering from the syndrome in 2012, according to the National Institute on Drug Abuse.

    Babies born with NAS may suffer seizures, high fevers, vomiting, diarrhea and severe distress. They require weeks of inpatient treatment with drips of morphine or methadone. The long-term effects of this drug treatment are unknown. Hospital care typically costs $50,000 to $60,000.

    In Tennessee alone, treatment for NAS babies cost the state Medicaid program more than $60 million last year, Towers said. If detox could reduce the number of NAS cases, he said, the state could take those savings and fund addiction treatment programs for pregnant women. He's currently talking with Medicaid officials about developing such programs.

    Towers is also working with Dr. Geogy Thomas in the small eastern Tennessee town of Jellico—where about 60 babies with NAS were born last year—to launch an inpatient detox program for pregnant women. Thomas is trying to persuade Medicaid managed-care plans to adequately pay for these services.

    “The best thing is to get moms off drugs when they are pregnant, when they're concerned about their fetus, and we've got their attention,” Thomas said.

    In Towers' study, one group of patients received slow outpatient treatment with buprenorphine combined with intensive behavioral healthcare; the NAS rate for their babies was 17.2%. Two groups received rapid inpatient treatment with buprenorphine. One of the inpatient groups also received residential behavioral care; their NAS rate was 17.4%. The other inpatient group did not receive residential behavioral care and had an NAS rate of 70.1%. A fourth group was incarcerated and went through cold-turkey withdrawal. Their babies' NAS rate was 18.5%.

    Towers said his addicted pregnant patients are motivated to get off drugs “because they have someone else they are responsible for.”

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    diversity
    Health equity execs leveraging academic roles to drive long-term change
    Patrick Blair InnovAge
    PACE could expand amid possible nursing home closures: InnovAge CEO
    Most Popular
    1
    Centene to lay off 2,000 workers
    2
    How health systems are battling price-gouging allegations
    3
    Senate advances bill to temporarily aid hospitals, health centers
    4
    Elevance, Blue Cross Louisiana halt $2.5B proposed deal
    5
    Tower Health to sell urgent care centers, close others
    Sponsored Content
    Modern Healthcare A.M. Newsletter: Sign up to receive a comprehensive weekday morning newsletter designed for busy healthcare executives who need the latest and most important healthcare news and analysis.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Help Center
    • Advertise with Us
    • Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Blogs
      • AI
      • Deals
      • Layoff Tracker
      • HIMSS 2023
    • Opinion
      • Breaking Bias
      • Commentaries
      • Letters
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Excellence in Governance
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top Innovators
        • Diversity in Healthcare
          • - Luminaries
          • - Top 25 Diversity Leaders
          • - Leaders to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Conferences
        • Digital Health Transformation Summit
        • ESG: The Implementation Imperative Summit
        • Leadership Symposium
        • Social Determinants of Health Symposium
        • Women Leaders in Healthcare Conference
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Diversity Leaders Gala
        • Top 25 Women Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Hospital at Home
        • - Workplace of the Future
        • - AI and Digital Health
        • - Future of Staffing
        • - Hospital of the Future (Fall)
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Sponsored Video Series - One on One
      • Sponsored Video Series - Checking In with Dan Peres
    • Data & Insights
      • Data & Insights Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing